Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Monogram Technologies Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
MGRM
Nasdaq
3840
www.monogramtechnologies.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Monogram Technologies Inc.
MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00
- May 16th, 2025 8:05 am
Monogram Technologies Inc (MGRM) Q1 2025 Earnings Call Highlights: FDA Clearance and Strategic ...
- May 15th, 2025 7:00 pm
Monogram Technologies Reports First Quarter 2025 Financial Results
- May 14th, 2025 2:01 pm
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
- May 6th, 2025 6:31 am
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
- Apr 29th, 2025 9:55 am
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
- Apr 29th, 2025 4:00 am
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
- Mar 20th, 2025 12:15 pm
MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.
- Mar 20th, 2025 9:03 am
Monogram Technologies And Two More Penny Stocks To Watch
- Mar 18th, 2025 5:05 am
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
- Mar 17th, 2025 5:00 am
MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results
- Mar 13th, 2025 9:16 am
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
- Mar 12th, 2025 5:15 pm
Monogram Technologies Reports Full Year 2024 Financial Results
- Mar 12th, 2025 2:01 pm
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
- Mar 5th, 2025 6:31 am
Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time
- Feb 27th, 2025 6:31 am
MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00.
- Feb 27th, 2025 2:27 am
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India
- Feb 26th, 2025 6:31 am
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
- Dec 18th, 2024 6:31 am
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
- Dec 2nd, 2024 2:05 pm
MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00.
- Nov 21st, 2024 10:12 am
Scroll